1995 Results

People

  1. Kris
    Kris
  2. Motzer
    Motzer
  3. Scher
    Scher
  4. Saltz
    Saltz
  5. Schwartz
    Schwartz
  6. Hudis
    Hudis
  7. Kelsen
    Kelsen
  8. Rosen
    Rosen
  9. Marks
    Marks
  10. De Angelis
    De Angelis

Groups

  1. Department of Medicine (969)
  2. Solid Tumor Oncology Division (729)
  3. Surgery (289)
  4. GSK Faculty (287)
  5. Survivorship Research (260)
  6. Center for Hematologic Malignancies (230)
  7. Sloan Kettering Institute Faculty (227)
  8. Hematologic Malignancies, Division of (224)
  9. Genitourinary Oncology Service (203)
  10. Molecular Pharmacology and Chemistry Program Faculty (172)
  1. "antineoplastic agents"
Formats
  1. Journal Article (1901)
  2. Review (47)
  3. Conference Paper (23)
  4. Editorial (7)
  5. Research Letter (6)
  6. Guidelines (4)
  7. Book Section (3)
  8. Correspondence (2)
  9. Meeting Abstract (1)
  10. Miscellaneous (1)
Groups
  1. Department of Medicine (969)
  2. Solid Tumor Oncology Division (729)
  3. Surgery (289)
  4. GSK Faculty (287)
  5. Survivorship Research (260)
  6. Center for Hematologic Malignancies (230)

More Groups

People
  1. Mark Kris (77)
  2. Robert Motzer (70)
  3. Howard Scher (58)
  4. Gary Schwartz (52)
  5. Leonard Saltz (52)
  6. Ting-Chao Chou (50)

More People

Years
  1. 2025 (16)
  2. 2024 (65)
  3. 2023 (49)
  4. 2022 (49)
  5. 2021 (11)
  6. 2020 (4)

More Years

Publications
  1. Clinical Cancer Research (114)
  2. Journal of Clinical Oncology (111)
  3. Cancer (70)
  4. Seminars in Oncology (51)
  5. New England Journal of Medicine (43)
  6. Cancer Research (40)

More Publications

Publishers
  1. Elsevier Inc. (240)
  2. American Association for Cancer Research (187)
  3. Springer (175)
  4. American Society of Clinical Oncology (129)
  5. Wiley Blackwell (112)
  6. Nature Publishing Group (92)

More Publishers

Results (1995)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Survival outcomes of men with lymph node-positive prostate cancer after radical prostatectomy: A comparative analysis of different postoperative management strategies
    Journal Article

    Touijer, K. A.; Karnes, R. J.; Passoni, N.; Sjoberg, D. D.; Assel, M.; Fossati, N.; Gandaglia, G.; Eastham, J. A.; Scardino, P. T.; Vickers, A.; more...
    European Urology (2018)

    Fulltext@MSK | Save
  • Management of patients with adenocarcinoma or squamous cancer of the esophagus
    Journal Article

    Ilson, D. H.; van Hillegersberg, R.
    Gastroenterology (2018)

    Fulltext@MSK | Save
  • The financial burden and distress of patients with cancer: Understanding and stepping-up action on the financial toxicity of cancer treatment
    Journal Article

    Carrera, P. M.; Kantarjian, H. M.; Blinder, V. S.
    CA - A Cancer Journal for Clinicians (2018)

    Fulltext@MSK | Save
  • Efficacy of larotrectinib in TRK fusion-positive cancers in adults and children
    Journal Article

    Drilon, A.; Laetsch, T. W.; Kummar, S.; DuBois, S. G.; Lassen, U. N.; Demetri, G. D.; Nathenson, M.; Doebele, R. C.; Farago, A. F.; Pappo, A. S.; more...
    New England Journal of Medicine (2018)

    Fulltext@MSK | Save
  • Frequency and level of evidence used in recommendations by the National Comprehensive Cancer Network guidelines beyond approvals of the US Food and Drug Administration: Retrospective observational study
    Journal Article

    Wagner, J.; Marquart, J.; Ruby, J.; Lammers, A.; Mailankody, S.; Kaestner, V.; Prasad, V.
    BMJ: British Medical Journal (International Edition) (2018)

    Fulltext@MSK | Save
  • Treatment of advanced melanoma - A changing landscape
    Journal Article

    Hepner, A.; Salgues, A.; dos Anjos, C. A.; Sahade, M.; Camargo, V. P.; Garicochea, B.; Shoushtari, A. N.; Postow, M. A.; Fernandes, G. S.; Munhoz, R. R.
    Revista Da Associacao Medica Brasileira (2017)

    Fulltext@MSK | Save
  • Clinical and morphologic characteristics of MEK inhibitor - Associated retinopathy: Differences from central serous chorioretinopathy
    Journal Article

    Francis, J. H.; Habib, L. A.; Abramson, D. H.; Yannuzzi, L. A.; Heinemann, M.; Gounder, M. M.; Grisham, R. N.; Postow, M. A.; Shoushtari, A. N.; Chi, P.; more...
    Ophthalmology (2017)

    Fulltext@MSK | Save
  • Fusions in solid tumours: Diagnostic strategies, targeted therapy, and acquired resistance
    Journal Article

    Schram, A. M.; Chang, M. T.; Jonsson, P.; Drilon, A.
    Nature Reviews Clinical Oncology (2017)

    Fulltext@MSK | Save
  • Nivolumab versus docetaxel in previously treated patients with advanced non-small-cell lung cancer: Two-year outcomes from two randomized, open-label, phase III trials (CheckMate 017 and CheckMate 057)
    Journal Article

    Horn, L.; Spigel, D. R.; Vokes, E. E.; Holgado, E.; Ready, N.; Steins, M.; Poddubskaya, E.; Borghaei, H.; Felip, E.; Paz-Ares, L.; more...
    Journal of Clinical Oncology (2017)

    Fulltext@MSK | Save
  • FDA approval of tisagenlecleucel: Promise and complexities of a $475 000 cancer drug
    Journal Article

    Bach, P. B.; Giralt, S. A.; Saltz, L. B.
    JAMA - Journal of the American Medical Association (2017)

    Fulltext@MSK | Save